Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation - Enkhbaatar,P.; Okajima,K.; Murakami,K. (Am J Respir Crit Care Med, 2000)